Global Pharmaceutical Grade Grape Seed Extract Market Strategic Research Report

Scope of the Report

The global Pharmaceutical Grade Grape Seed Extract market size is predicted to grow from US$ 77.48 million in 2025 to US$ 152 million in 2032; it is expected to grow at a CAGR of 10.2% from 2026 to 2032.

Pharmaceutical-grade grape seed extract refers to a plant extract obtained from the seeds of grapes (Vitis vinifera), a plant belonging to the genus Vitis vinifera in the Vitaceae family, through processes such as extraction, separation, purification, and drying using water or ethanol-water solutions. Its core active ingredient is oligomeric proanthocyanidins.

Pharmaceutical-grade grape seed extract is a uniform powder free of visible foreign matter, light brownish-yellow to brownish-red, with a faint odor and a slightly bitter taste.

The upstream raw material for pharmaceutical-grade grape seed extract is the seeds of plants in the genus Vitis vinifera, primarily a byproduct of wine grapes, with a small amount from specialized extraction varieties. Midstream extraction processes include countercurrent extraction with water/ethanol-water solutions or supercritical CO₂ extraction. Key purification steps include macroporous adsorption resin chromatography (separating polyphenols from impurities and improving proanthocyanidin purity), membrane separation technology (removing large molecular impurities and retaining oligomeric proanthocyanidins), and activated carbon decolorization (improving product color to meet pharmaceutical-grade appearance requirements). Downstream applications include pharmaceutical raw materials, health products, and nutritional supplements.

In 2025, global sales of pharmaceutical-grade grape seed extract reached 480 tons, with a production capacity of approximately 650 tons, an average selling price of US$165/kg, and an average gross profit margin of 38%-45%.

Global key Pharmaceutical Grade Grape Seed Extract players cover Indena SPA, Polyphenolics, Langlin Biological, GRAP'SUD, Chenguang Biotech, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Grade Grape Seed Extract market?

What factors are driving Pharmaceutical Grade Grape Seed Extract market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Grade Grape Seed Extract market opportunities vary by end market size?

How does Pharmaceutical Grade Grape Seed Extract break out by Type, by Application?

This report presents a comprehensive overview of the global Pharmaceutical Grade Grape Seed Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• OPC Concentration 95%-98%
• OPC Concentration ≥98%

Segment by Physical Form

• Powder
• Water-Soluble
• Microencapsulated

Segment by Production Processes

• Solvent Extraction
• Supercritical CO₂ Extraction
• Membrane Separation Technology

Segment by Application

• Pharmaceutical Raw Materials
• Health Products
• Nutritional Supplements

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pharmaceutical Grade Grape Seed Extract market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmaceutical Raw Materials, Health Products, Nutritional Supplements evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact